ArticleReproductive biology and endocrinology : RB&E2026
Impact of ovarian stimulation duration in GnRH antagonist protocols on the cumulative ongoing pregnancy rate in women with normal ovarian reserve: a cohort study.
Article in Reproductive biology and endocrinology : RB&E, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of estradiol and progesterone levels on human chorionic gonadotropin day with pregnancy outcomes in IVF/ICSI fresh embryo transfer.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe optimal duration of ovarian stimulation in GnRH antagonist protocols remains insufficiently explored, despite its potential impact on oocyte quality, embryo development, and endometrial receptivity. Identifying an optimal stimulation window may improve success rates in assisted reproductive technologies (ART) while minimizing unnecessary hormonal exposure. The aim of the study was to evaluate if the duration of ovarian stimulation in GnRH antagonist IVF/ICSI protocols influence cumulative ongoing pregnancy rates (COPR).
methodsThis retrospective single-centre study analyzed 1456 IVF/ICSI cycles conducted between 2019 and 2023 in women with normal ovarian reserve using an antagonist protocol. Stimulation duration was classified into three categories: ≤ 8 days, 9-13 days (reference), and ≥ 14 days corresponding to the ≤ 5th, 5th-95th, and ≥ 95th percentiles, respectively. Clinical, biological, and embryological outcomes were compared across groups using the Kruskal-Wallis test. Logistic regression was applied to identify independent predictors of cumulative ongoing pregnancy and pregnancy outcomes.
resultsA total of 1456 cycles were included in the study. At least one embryo was obtained in 95.2% of cycles, with 69.5% proceeding to fresh transfer. Cumulative ongoing pregnancy was assessed for 1339 cycles, among which 36.4% resulted in an ongoing pregnancy. Stimulation duration did not significantly influence COPR: ≤ 8 days (OR = 1.04, 95% CI 0.78-1.39), 9-13 days (reference), ≥ 14 days (OR = 0.84, 95% CI 0.64-1.11). Multivariate analysis identified younger age and higher AMH as independent predictors of COPR.
conclusionsIn women with normal ovarian reserve undergoing IVF/ICSI with a GnRH antagonist protocol, the duration of ovarian stimulation does not significantly impact cumulative pregnancy outcomes. These findings support a personalized approach to trigger timing based on ovarian response independent of stimulation length.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.